Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21)
The summary for the Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21): -Purpose. This Funding Opportunity Announcement (FOA) issued by National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, solicits Research Grant (R21) applications from institutions/organizations that propose to investigate the underlying molecular mechanisms of the development as well as reversal of alcohol-induced liver fibrosis. Liver fibrosis comprises excessive deposition of extracellular matrix (ECM) components, especially collagen, and activation of hepatic stellate cells (HSCs) is the primary event that triggers the process of fibrogenesis. Understanding the mechanisms of alcohol-induced liver fibrosis is important for the development of strategies for prevention and treatment of this condition. This FOA encourages applicants to test small molecules that reverse or prevent alcohol-induced liver fibrosis. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R21) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-360 that solicits applications under the R01 mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
| Federal Grant Title: | Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PA-07-361 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.273 |
| CFDA Descriptions: | Alcohol Research Programs |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
| Posted Date: | Apr 19, 2007 |
| Creation Date: | Apr 19, 2007 |
| Archive Date: | Dec 05, 2008 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Specialized Alcohol Research Centers (P50 Clinical trial Optional)
- • Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Stud...
- • Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Stud...
- • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- • NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (...
- • Mechanisms of Alcoholic Pancreatitis
- • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
- • Mechanisms of Alcohol-Induced Tissue Injury
- More Grants from the National Institutes of Health
- • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
- • Immune Tolerance Network (UM1 Clinical Trial Required)
- • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
- • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
- • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...
